Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease

NCT ID: NCT06268886

Last Updated: 2025-07-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE2

Total Enrollment

310 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-20

Study Completion Date

2027-03-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alzheimer Disease, Early Onset

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Specified dose on specified days

BMS-986446 Dose A

Group Type EXPERIMENTAL

BMS-986446

Intervention Type DRUG

Specified dose on specified days

BMS-986446 Dose B

Group Type EXPERIMENTAL

BMS-986446

Intervention Type DRUG

Specified dose on specified days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BMS-986446

Specified dose on specified days

Intervention Type DRUG

Placebo

Specified dose on specified days

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild AD dementia consistent with the National Institute on Aging and the Alzheimer's Association (NIA-AA) core clinical criteria.
* Global Clinical Dementia Rating (CDR) score of 0.5 to 1.0 and a CDR-Memory Box score of 0.5 and greater at screening and Baseline.
* Evidence of AD pathology.
* Objective impairment in episodic memory as indicated by at least 1 standard deviation below age-adjusted mean in the Wechsler Memory Scale IV-Logical Memory Subtest II (WMS-IV LM II).
* Mini Mental Status Examination (MMSE) score ≥ 20 to 28 (inclusive).

Exclusion Criteria

* Any evidence of a condition that may affect cognition other than AD.
* Contraindications to PET imaging.
* Inability to tolerate or contraindication to magnetic resonance imaging.
* Any serious medical condition that could, in the opinion of the investigator, affect the participant's safety or interfere with study assessments.
* Geriatric Depression Scale (GDS) score greater than or equal to 8 at screening.
Minimum Eligible Age

50 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bristol-Myers Squibb

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bristol-Myers Squibb

Role: STUDY_DIRECTOR

Bristol-Myers Squibb

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Local Institution - 0068

Chandler, Arizona, United States

Site Status

Local Institution - 0102

Gilbert, Arizona, United States

Site Status

Local Institution - 0019

Phoenix, Arizona, United States

Site Status

Local Institution - 0018

Scottsdale, Arizona, United States

Site Status

Local Institution - 0026

Scottsdale, Arizona, United States

Site Status

Local Institution - 0077

Tucson, Arizona, United States

Site Status

Local Institution - 0038

Tucson, Arizona, United States

Site Status

Local Institution - 0164

Encino, California, United States

Site Status

Local Institution - 0139

Fullerton, California, United States

Site Status

Local Institution - 0191

Irvine, California, United States

Site Status

Local Institution - 0234

Long Beach, California, United States

Site Status

Local Institution - 0142

Los Alamitos, California, United States

Site Status

Local Institution - 0037

Napa, California, United States

Site Status

Local Institution - 0209

Sacramento, California, United States

Site Status

Local Institution - 0052

San Francisco, California, United States

Site Status

Local Institution - 0137

Santa Ana, California, United States

Site Status

Local Institution - 0046

Sherman Oaks, California, United States

Site Status

Local Institution - 0106

Danbury, Connecticut, United States

Site Status

Local Institution - 0148

New Haven, Connecticut, United States

Site Status

Local Institution - 0056

New Haven, Connecticut, United States

Site Status

Local Institution - 0153

Stamford, Connecticut, United States

Site Status

Local Institution - 0022

Altamonte Springs, Florida, United States

Site Status

Local Institution - 0048

Atlantis, Florida, United States

Site Status

Local Institution - 0228

Boca Raton, Florida, United States

Site Status

Local Institution - 0250

Boca Raton, Florida, United States

Site Status

Local Institution - 0224

Bradenton, Florida, United States

Site Status

Local Institution - 0020

Clermont, Florida, United States

Site Status

Local Institution - 0009

Daytona Beach, Florida, United States

Site Status

Local Institution - 0213

Fort Myers, Florida, United States

Site Status

Local Institution - 0059

Greenacres City, Florida, United States

Site Status

Local Institution - 0207

Hialeah, Florida, United States

Site Status

Local Institution - 0212

Hialeah, Florida, United States

Site Status

Local Institution - 0198

Hialeah, Florida, United States

Site Status

Local Institution - 0151

Lady Lake, Florida, United States

Site Status

Local Institution - 0146

Lakeland, Florida, United States

Site Status

Local Institution - 0192

Maitland, Florida, United States

Site Status

Local Institution - 0143

Maitland, Florida, United States

Site Status

Local Institution - 0027

Merritt Island, Florida, United States

Site Status

Local Institution - 0203

Miami, Florida, United States

Site Status

Local Institution - 0058

Miami, Florida, United States

Site Status

Local Institution - 0034

Miami, Florida, United States

Site Status

Local Institution - 0211

Miami, Florida, United States

Site Status

Local Institution - 0195

Miami, Florida, United States

Site Status

Local Institution - 0014

Miami, Florida, United States

Site Status

Local Institution - 0005

Miami, Florida, United States

Site Status

Local Institution - 0208

Miami, Florida, United States

Site Status

Local Institution - 0013

Miami, Florida, United States

Site Status

Local Institution - 0008

Miami, Florida, United States

Site Status

Local Institution - 0199

Miami, Florida, United States

Site Status

Local Institution - 0206

Miami, Florida, United States

Site Status

Local Institution - 0176

Miami, Florida, United States

Site Status

Local Institution - 0071

Miami, Florida, United States

Site Status

Local Institution - 0156

Miami, Florida, United States

Site Status

Local Institution - 0249

Miami, Florida, United States

Site Status

Local Institution - 0039

Miami, Florida, United States

Site Status

Local Institution - 0225

Miami, Florida, United States

Site Status

Local Institution - 0197

Miami Springs, Florida, United States

Site Status

Local Institution - 0217

Naples, Florida, United States

Site Status

Local Institution - 0017

New Port Richey, Florida, United States

Site Status

Local Institution - 0144

Ocala, Florida, United States

Site Status

Local Institution - 0202

Orlando, Florida, United States

Site Status

Local Institution - 0219

Orlando, Florida, United States

Site Status

Local Institution - 0035

Orlando, Florida, United States

Site Status

Local Institution - 0238

Orlando, Florida, United States

Site Status

Local Institution - 0210

Port Orange, Florida, United States

Site Status

Local Institution - 0204

Sarasota, Florida, United States

Site Status

Local Institution - 0012

Stuart, Florida, United States

Site Status

Local Institution - 0136

Stuart, Florida, United States

Site Status

Local Institution - 0200

Tampa, Florida, United States

Site Status

Local Institution - 0080

Tampa, Florida, United States

Site Status

Local Institution - 0087

Tampa, Florida, United States

Site Status

Local Institution - 0042

Tampa, Florida, United States

Site Status

Local Institution - 0194

Viera, Florida, United States

Site Status

Local Institution - 0011

Wellington, Florida, United States

Site Status

Local Institution - 0223

West Palm Beach, Florida, United States

Site Status

Local Institution - 0149

West Palm Beach, Florida, United States

Site Status

Local Institution - 0029

Windermere, Florida, United States

Site Status

Local Institution - 0101

Winter Park, Florida, United States

Site Status

Local Institution - 0154

Winter Park, Florida, United States

Site Status

Local Institution - 0105

Columbus, Georgia, United States

Site Status

Local Institution - 0236

Chicago, Illinois, United States

Site Status

Local Institution - 0021

Chicago, Illinois, United States

Site Status

Local Institution - 0161

Elk Grove Village, Illinois, United States

Site Status

Local Institution - 0003

Gurnee, Illinois, United States

Site Status

Local Institution - 0145

Park Ridge, Illinois, United States

Site Status

Local Institution - 0081

Springfield, Illinois, United States

Site Status

Local Institution - 0235

Boston, Massachusetts, United States

Site Status

Local Institution - 0025

Boston, Massachusetts, United States

Site Status

Local Institution - 0015

Braintree, Massachusetts, United States

Site Status

Local Institution - 0174

Foxborough, Massachusetts, United States

Site Status

Local Institution - 0118

Methuen, Massachusetts, United States

Site Status

Local Institution - 0040

Newton, Massachusetts, United States

Site Status

Local Institution - 0120

Plymouth, Massachusetts, United States

Site Status

Local Institution - 0045

Watertown, Massachusetts, United States

Site Status

Local Institution - 0119

Portsmouth, New Hampshire, United States

Site Status

Local Institution - 0031

Princeton, New Jersey, United States

Site Status

Local Institution - 0062

Toms River, New Jersey, United States

Site Status

Local Institution - 0060

Albany, New York, United States

Site Status

Local Institution - 0157

Amherst, New York, United States

Site Status

Local Institution - 0061

Manhasset, New York, United States

Site Status

Local Institution - 0205

New York, New York, United States

Site Status

Local Institution - 0214

New York, New York, United States

Site Status

Local Institution - 0104

New York, New York, United States

Site Status

Local Institution - 0133

New York, New York, United States

Site Status

Local Institution - 0043

Matthews, North Carolina, United States

Site Status

Local Institution - 0215

Dayton, Ohio, United States

Site Status

Local Institution - 0155

Independence, Ohio, United States

Site Status

Local Institution - 0023

Plymouth Meeting, Pennsylvania, United States

Site Status

Local Institution - 0024

East Providence, Rhode Island, United States

Site Status

Local Institution - 0163

Providence, Rhode Island, United States

Site Status

Local Institution - 0132

Cordova, Tennessee, United States

Site Status

Local Institution - 0140

Franklin, Tennessee, United States

Site Status

Local Institution - 0222

Nashville, Tennessee, United States

Site Status

Local Institution - 0069

Austin, Texas, United States

Site Status

Local Institution - 0033

Beaumont, Texas, United States

Site Status

Local Institution - 0051

Dallas, Texas, United States

Site Status

Local Institution - 0016

Houston, Texas, United States

Site Status

Local Institution - 0196

Fairfax, Virginia, United States

Site Status

Local Institution - 0168

Richmond, Virginia, United States

Site Status

Local Institution - 0111

East Gosford, New South Wales, Australia

Site Status

Local Institution - 0170

Macquarie Park, New South Wales, Australia

Site Status

Local Institution - 0116

Griffith University, Queensland, Australia

Site Status

Local Institution - 0115

Carlton North, Victoria, Australia

Site Status

Local Institution - 0093

Ivanhoe, Victoria, Australia

Site Status

Local Institution - 0001

Malvern, Victoria, Australia

Site Status

Local Institution - 0125

Melbourne, Victoria, Australia

Site Status

Local Institution - 0147

Parkville, Victoria, Australia

Site Status

Local Institution - 0094

Nedlands, Western Australia, Australia

Site Status

Local Institution - 0122

Anderlecht, Brussels Capital, Belgium

Site Status

Local Institution - 0175

Antwerpen, Brussels Capital, Belgium

Site Status

Local Institution - 0082

Kortrijk, VWV, Belgium

Site Status

Local Institution - 0097

Brussels, , Belgium

Site Status

Local Institution - 0076

Leuven, , Belgium

Site Status

Local Institution - 0112

Ottawa, Ontario, Canada

Site Status

Local Institution - 0047

Toronto, Ontario, Canada

Site Status

Local Institution - 0044

Toronto, Ontario, Canada

Site Status

Local Institution - 0109

Toronto, Ontario, Canada

Site Status

Local Institution - 0113

Greenfield Park, Quebec, Canada

Site Status

Local Institution - 0248

Montreal, Quebec, Canada

Site Status

Local Institution - 0053

Québec, , Canada

Site Status

Local Institution - 0181

Nagoya, Aichi-ken, Japan

Site Status

Local Institution - 0227

Toride-Shi, Ibaraki, Japan

Site Status

Local Institution - 0186

Kurashiki-Shi, Okayama-ken, Japan

Site Status

Local Institution - 0242

Hirakata-Shi, Osaka, Japan

Site Status

Local Institution - 0253

Osaka, Osaka, Japan

Site Status

Local Institution - 0185

Bunkyo-Ku, Tokyo, Japan

Site Status

Local Institution - 0218

Hachioji-Shi, Tokyo, Japan

Site Status

Local Institution - 0184

Setagaya-Ku, Tokyo, Japan

Site Status

Local Institution - 0226

Chūōku, , Japan

Site Status

Local Institution - 0190

Himeji-shi, , Japan

Site Status

Local Institution - 0188

Kasukabe-Shi, , Japan

Site Status

Local Institution - 0179

Kodaira-Shi, , Japan

Site Status

Local Institution - 0221

Musashimurayama-Shi, , Japan

Site Status

Local Institution - 0220

Musashino-shi, , Japan

Site Status

Local Institution - 0180

Nagoya, , Japan

Site Status

Local Institution - 0178

Osaka, , Japan

Site Status

Local Institution - 0232

Ōbu, , Japan

Site Status

Local Institution - 0240

Tachikawa-Shi, , Japan

Site Status

Local Institution - 0239

Takatsuki-Shi, , Japan

Site Status

Local Institution - 0189

Toyonaka-Shi, , Japan

Site Status

Local Institution - 0091

Singapore, , Singapore

Site Status

Local Institution - 0117

Songpa-gu, Seoul, South Korea

Site Status

Local Institution - 0110

Gwangjingu, , South Korea

Site Status

Local Institution - 0050

Incheon, , South Korea

Site Status

Local Institution - 0114

Junggu, , South Korea

Site Status

Local Institution - 0158

Barcelona, B, Spain

Site Status

Local Institution - 0054

Sant Cugat del Vallès, CT, Spain

Site Status

Local Institution - 0231

Lleida, L, Spain

Site Status

Local Institution - 0096

Barcelona, , Spain

Site Status

Local Institution - 0171

Barcelona, , Spain

Site Status

Local Institution - 0172

Barcelona, , Spain

Site Status

Local Institution - 0167

Malmo, M, Sweden

Site Status

Local Institution - 0121

Enfield, LND, United Kingdom

Site Status

Local Institution - 0252

London, LND, United Kingdom

Site Status

Local Institution - 0247

Bath, SOM, United Kingdom

Site Status

Local Institution - 0089

Chertsey, Surrey, United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Australia Belgium Canada Japan Singapore South Korea Spain Sweden United Kingdom

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-504840-32

Identifier Type: OTHER

Identifier Source: secondary_id

U1111-1290-3539

Identifier Type: REGISTRY

Identifier Source: secondary_id

CN008-0003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy of MT-4666
NCT01764243 COMPLETED PHASE2